35 related articles for article (PubMed ID: 16531121)
1. Impaired functional capacities of liver dendritic cells from murine hepatitis B virus (HBV) carriers: relevance to low HBV-specific immune responses.
Hasebe A; Akbar SM; Furukawa S; Horiike N; Onji M
Clin Exp Immunol; 2005 Jan; 139(1):35-42. PubMed ID: 15606611
[TBL] [Abstract][Full Text] [Related]
2. In-vitro activation of cytotoxic T lymphocytes by fusion of mouse hepatocellular carcinoma cells and lymphotactin gene-modified dendritic cells.
Sheng XL; Zhang H
World J Gastroenterol; 2007 Nov; 13(44):5944-50. PubMed ID: 17990361
[TBL] [Abstract][Full Text] [Related]
3. Activation of cytotoxic T lymphocytes against CML28-bearing tumors by dendritic cells transduced with a recombinant adeno-associated virus encoding the CML28 gene.
Xie LH; Sin FW; Cheng SC; Cheung YK; Chan KT; Xie Y; Xie Y
Cancer Immunol Immunother; 2008 Jul; 57(7):1029-38. PubMed ID: 18157497
[TBL] [Abstract][Full Text] [Related]
4. Mimovirus: a novel form of vaccine that induces hepatitis B virus-specific cytotoxic T-lymphocyte responses in vivo.
Wu YZ; Zhao JP; Wan Y; Jia ZC; Zhou W; Bian J; Ni B; Zou LY; Tang Y
J Virol; 2002 Oct; 76(20):10264-9. PubMed ID: 12239302
[TBL] [Abstract][Full Text] [Related]
5. A novel adjuvant Ling Zhi-8 enhances the efficacy of DNA cancer vaccine by activating dendritic cells.
Lin CC; Yu YL; Shih CC; Liu KJ; Ou KL; Hong LZ; Chen JD; Chu CL
Cancer Immunol Immunother; 2011 Jul; 60(7):1019-27. PubMed ID: 21499904
[TBL] [Abstract][Full Text] [Related]
6. Avasimibe can cooperate with a DC-targeting and integration-deficient lentivector to induce stronger HBV specific T cytotoxic response by regulating cholesterol metabolism.
Ma S; Lv M; Chen X; Zang G; Tang Z; Zhang Y; Hu W
Antiviral Res; 2023 Aug; 216():105662. PubMed ID: 37393054
[TBL] [Abstract][Full Text] [Related]
7. HBVsvp-Pulsed Dendritic Cell Immunotherapy Induces Th1 Polarization and Hepatitis B Virus-Specific Cytotoxic T Lymphocytes Production.
Farag MMS; Suef RA; Al-Toukhy GM; Selim MA; Elbahnasawy MA; El Sharkawy N; Ezzat S; Shebl N; Mansour MTM
Infect Drug Resist; 2020; 13():2699-2709. PubMed ID: 32821133
[TBL] [Abstract][Full Text] [Related]
8. Characterization Of The Interaction Between Subviral Particles Of Hepatitis B Virus And Dendritic Cells - In Vitro Study.
Farag MM; Peschel G; Müller M; Weigand K
Infect Drug Resist; 2019; 12():3125-3135. PubMed ID: 31632101
[TBL] [Abstract][Full Text] [Related]
9. Tapasin modification on the intracellular epitope HBcAg18-27 enhances HBV-specific CTL immune response and inhibits hepatitis B virus replication in vivo.
Chen X; Tang Y; Zhang Y; Zhuo M; Tang Z; Yu Y; Zang G
Lab Invest; 2014 May; 94(5):478-90. PubMed ID: 24614195
[TBL] [Abstract][Full Text] [Related]
10. Enhancing the immunogenicity of exogenous hepatitis B surface antigen-based vaccines for MHC-I-restricted T cells.
Schirmbeck R; Reimann J
Biol Chem; 1999 Mar; 380(3):285-91. PubMed ID: 10223330
[TBL] [Abstract][Full Text] [Related]
11. DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response.
Whalen RG; Leclerc C; Dériaud E; Schirmbeck R; Reimann J; Davis HL
Ann N Y Acad Sci; 1995 Nov; 772():64-76. PubMed ID: 8546414
[TBL] [Abstract][Full Text] [Related]
12. Induction of Tc1 response and enhanced cytotoxic T lymphocyte activity in mice by dendritic cells transduced with adenovirus expressing HBsAg.
Huang Y; Chen Z; Jia H; Wu W; Zhong S; Zhou C
Clin Immunol; 2006 Jun; 119(3):280-90. PubMed ID: 16531121
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice.
Shimizu Y; Guidotti LG; Fowler P; Chisari FV
J Immunol; 1998 Nov; 161(9):4520-9. PubMed ID: 9794377
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of dendritic cell-based immunization against HBV in transgenic mice.
Jiang WZ; Fan Y; Liu X; Zhang YL; Wen JJ; Hao WL; Qian M
Antiviral Res; 2008 Jan; 77(1):50-5. PubMed ID: 17897731
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine.
Zhou C; Peng G; Jin X; Tang J; Chen Z
Clin Immunol; 2010 Nov; 137(2):190-8. PubMed ID: 20692873
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
